Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $26.1700 (-3.25%) ($26.0130 - $27.0050) on Fri. Oct. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.92% (three month average) | RSI | 51 | Latest Price | $26.1700(-3.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.1% a day on average for past five trading days. | Weekly Trend | TGTX advances 2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -1.96% in a week (0% probabilities). VIXM(-37%) VXX(-33%) UUP(-18%) DRIV(-6%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.96% (StdDev 3.92%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $26.32(-0.57%) | 10 Day Moving Average | $25.63(2.11%) | 20 Day Moving Average | $25.36(3.19%) | To recent high | -3.9% | To recent low | 41.6% | Market Cap | $3.314b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |